Announcements

Job offersmore »

Tweeting Growers

Top 5 - yesterday

  • No news has been published yesterday.

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




Cucumber mosaic virus and the fight against Alzheimer's

Research from the Universities of Dundee and Oxford has shown how combining the tetanus vaccine with a viral particle that normally affects cucumbers can be used to treat psoriasis and allergies, and may even protect against Alzheimer’s disease.

Scientists led by Dundee’s Dr John Foerster and Oxford’s Professor Martin Bachmann, were able to take the protein coat of cucumber mosaic virus and incorporate a tetanus vaccine-derived protein structure known to stimulate the immune system in order to create vaccines to treat multiple chronic diseases.

The vaccine showed positive results in models of psoriasis and cat allergy and was shown to raise antibody levels thought to be beneficial in Alzheimer’s disease. These vaccines can be either preventative, which is the hope for Alzheimer’s but also therapeutic, meaning they can cure a disease like psoriasis after it has already been established.

More research is required to test the efficacy of the therapeutic in a clinical setting, but the Dundee-Oxford study raises the possibility of hundreds of thousands of people being spared the ravages of chronic diseases.

Dr Foerster said, “As an academic dermatologist with special interest in the immune system, my specific attention is on vaccines to be developed against chronic skin diseases. The idea is pretty simple – for diseases such as psoriasis or eczema, the newest and most effective medicines on the market are so-called ‘antibodies’, which are what you and I produce against bugs in a common cold.

“For chronic diseases, these antibodies are specially made against one of the body’s own proteins. By blocking that single protein, the disease gets better. To use the example of psoriasis, a protein called Interleukin 17 needs to be active for the disease to progress. By creating a vaccine that stimulates the body to make antibodies against Interleukin 17 itself we can replace the need for frequent and expensive injections and make this type of treatment much more affordable and accessible to patients who could otherwise not afford specially made antibodies.

“Our research shows that this technique works in mice and, importantly, our new vaccine technology shows that it is likely to be a more effective type of vaccine than existing ones in older people. Since many patients with chronic conditions like psoriasis are elderly this technology may work much better to obtain effective vaccines.”

The paper is published in the journal Nature Vaccines. The researchers are now looking to begin clinical testing of the vaccine and have already received regulatory approval to initiate testing in humans. Present antibodies for psoriasis treatment typically need to be injected at least once a month to keep working, and cost around Ł10,000 per patient annually. A vaccine would offer much more affordable treatment.

In Alzheimer’s, it is known that a protein called beta amyloid can cause brain damage resulting in inhibited function. Previous unsuccessful trials saw patients injected directly with antibodies against the same target but the new research suggests that starting the treatment – in the form of prophylactic vaccines – could provide a way of offering treatment even before the disease becomes clinically apparent. It is possible such prophylactic approach may work better and this could not be done using frequent antibody injections.

Professor Bachmann, Professor of Vaccinology at the Jenner Institute in Oxford, said, “Alzheimer's disease usually develops in elderly people. The fact that the vaccine described here is optimised for old individuals seems therefore particularly helpful. An additional important aspect of the current work is that we developed a platform technology and are currently broadening our preclinical studies to vaccines against Parkinson's disease as well as chronic pain.”

Source: University of Dundee

Publication date: 10/26/2017

 


 

Other news in this sector:

7/16/2018 Allergy potential of strawberries and tomatoes depends on the variety
7/12/2018 US (OH): Creating incentives for better food choices
7/10/2018 "School food policies have potential to improve health"
6/28/2018 EU: Call for best practices on healthy and sustainable food systems
6/19/2018 CAN (QC): Father sentenced over uneaten vegetables
5/18/2018 More than 100 types of herbs, throughout the year
5/17/2018 TV doctor reveals the one vegetable you need to boost your health
5/14/2018 Australia: Getting kids excited about eating vegetables
5/10/2018 Greater focus on vegetables in the UK
5/10/2018 More than 44,000 responses to future farming consultation
5/7/2018 Changes in personal income of U.S. counties 2000-2016
4/23/2018 Tomato Foundation Health Claim Project reaches 25% of funding target
4/19/2018 1-Minute Salad Maker
4/17/2018 Are micro leaves the next super vegetable?
4/16/2018 Pepper plant sops up personal care product antibiotic
4/6/2018 Red vs green peppers: which is healthier?
4/5/2018 Mexican researchers develop tomato that decreases hypertension
3/26/2018 Happy Spinach Day!
3/13/2018 A healthy look at art
3/7/2018 Health benefits of traditional Norwegian foods